<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7766402</article-id><article-id pub-id-type="pmid">33348773</article-id><article-id pub-id-type="doi">10.3390/nu12123859</article-id><article-id pub-id-type="publisher-id">nutrients-12-03859</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Improvement of Hypertriglyceridemia by Roasted <italic>Nelumbinis folium</italic> in High Fat/High Cholesterol Diet Rat Model</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0396-0862</contrib-id><name><surname>Kim</surname><given-names>Hye Yoom</given-names></name><xref ref-type="aff" rid="af1-nutrients-12-03859">1</xref><xref ref-type="aff" rid="af2-nutrients-12-03859">2</xref></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Mi Hyeon</given-names></name><xref ref-type="aff" rid="af1-nutrients-12-03859">1</xref><xref ref-type="aff" rid="af2-nutrients-12-03859">2</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Kwan Woo</given-names></name><xref ref-type="aff" rid="af1-nutrients-12-03859">1</xref></contrib><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>Jung Joo</given-names></name><xref ref-type="aff" rid="af1-nutrients-12-03859">1</xref><xref ref-type="aff" rid="af2-nutrients-12-03859">2</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jung Eun</given-names></name><xref ref-type="aff" rid="af3-nutrients-12-03859">3</xref></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Dae Gill</given-names></name><xref ref-type="aff" rid="af1-nutrients-12-03859">1</xref><xref ref-type="aff" rid="af2-nutrients-12-03859">2</xref><xref rid="c1-nutrients-12-03859" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Ho Sub</given-names></name><xref ref-type="aff" rid="af1-nutrients-12-03859">1</xref><xref ref-type="aff" rid="af2-nutrients-12-03859">2</xref><xref rid="c1-nutrients-12-03859" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-12-03859"><label>1</label>Hanbang Cardio-Renal Research Center &#x00026; Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan 54538, Korea; <email>hyeyoomc@naver.com</email> (H.Y.K.); <email>mihyeon123@naver.com</email> (M.H.H.); <email>swamp1@naver.com</email> (K.W.K.); <email>mora16@naver.com</email> (J.J.Y.)</aff><aff id="af2-nutrients-12-03859"><label>2</label>Department of Physiology, College of Oriental Medicine, Wonkwang University, Iksan 54538, Korea</aff><aff id="af3-nutrients-12-03859"><label>3</label>Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea; <email>steineun@kiom.re.kr</email></aff><author-notes><corresp id="c1-nutrients-12-03859"><label>*</label>Correspondence: <email>dgkang@wku.ac.kr</email> (D.G.K.); <email>host@wku.ac.kr</email> (H.S.L.); Tel.: +82-63-6447 (D.G.K. &#x00026; H.S.L.); Fax: +82-63-850-7260 (D.G.K. &#x00026; H.S.L.)</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>12</volume><issue>12</issue><elocation-id>3859</elocation-id><history><date date-type="received"><day>15</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Hypertriglyceridemia is a condition characterized by high triglyceride levels and is a major risk factor for the development of cardiovascular diseases. The present study was designed to investigate the inhibitory effect of roasted <italic>Nelumbinis folium</italic> (RN), which is a medicinal substance produced by heating lotus leaves, on lipid metabolism in high fat/cholesterol (HFC) diet-induced hypertriglyceridemia. Except for those in the control group, Sprague&#x02013;Dawley rats were fed an HFC diet for four weeks to induce hypertriglyceridemia. During the next nine weeks, the control, regular diet; HFC, HFC diet, FLU, fluvastatin (3 mg/kg/day); RNL, RN (100 mg/kg/day); RNH, RN (200 mg/kg/day) were orally administered together with the diet, and the experiments were conducted for a total of 13 weeks. The weight of the epididymal adipose tissue, liver, and heart of rats in the HFC diet group significantly increased compared to those in the control group but improved in the RN-treated group. It was also confirmed that vascular function, which is damaged by an HFC diet, was improved after RN treatment. The levels of insulin, glucose, triglycerides, total cholesterol, and low-density lipoprotein increased in the HFC diet group compared to those in the control group, while the administration of RN attenuated these parameters. In addition, the administration of RN significantly reduced the gene expression of both LXR and SREBP-1, which indicated the inhibitory effect of the biosynthesis of triglycerides caused by RN. The results indicated that RN administration resulted in an improvement in the overall lipid metabolism and a decrease in the concentration of triglycerides in the HFC diet-induced rat model of hypertriglyceridemia. Therefore, our findings suggest that the RN can be a candidate material to provide a new direction for treating hypertriglyceridemia.</p></abstract><kwd-group><kwd>roasted <italic>Nelumbinis folium</italic></kwd><kwd>high fat/cholesterol diet</kwd><kwd>hypertriglyceridemia</kwd><kwd>metabolic syndrome</kwd><kwd>obesity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-12-03859"><title>1. Introduction</title><p>An excessive intake of carbohydrates and animal fat increases the development of cardiovascular diseases [<xref rid="B1-nutrients-12-03859" ref-type="bibr">1</xref>]. Moreover, the risk of these diseases could be increased by hyperlipidemia, high blood pressure, diabetes, obesity, family history, smoking, stress, and lifestyle preferences. In particular, hyperlipidemia is the most important independent factor of coronary artery disease [<xref rid="B2-nutrients-12-03859" ref-type="bibr">2</xref>,<xref rid="B3-nutrients-12-03859" ref-type="bibr">3</xref>]. According to previously published reports, cancer, heart disease, cerebrovascular disease, ischemic heart disease, and cerebrovascular disease are associated with a high risk of mortality [<xref rid="B4-nutrients-12-03859" ref-type="bibr">4</xref>]. Hyperlipidemia and hypertriglyceridemia induced by an excessive intake of fat, sugar, saturated fatty acids, and cholesterol are associated with mortality [<xref rid="B3-nutrients-12-03859" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-12-03859" ref-type="bibr">4</xref>]. Hyperlipidemia and hypertriglyceridemia are associated with high blood triglyceride (TG) and high low-density lipoprotein (LDL) levels [<xref rid="B5-nutrients-12-03859" ref-type="bibr">5</xref>,<xref rid="B6-nutrients-12-03859" ref-type="bibr">6</xref>]. It is not yet known whether hyperlipidemia and hypertriglyceridemia are the primary causes of coronary diseases, but it is known that these diseases constitute major risk factors for the development of these disorders [<xref rid="B5-nutrients-12-03859" ref-type="bibr">5</xref>]. Restricting fat and cholesterol in patients with hypercholesteremia for six months resulted in significantly decreased LDL cholesterol levels in the blood and the decrease of arteriosclerosis, indicating that the intake of fat and cholesterol affects the development of hyperlipidemia and hypertriglyceridemia [<xref rid="B7-nutrients-12-03859" ref-type="bibr">7</xref>]. Fat is required to absorb fat-soluble vitamins or essential fatty acids, which serve as high-energy sources. However, excessive fat is converted to intestinal dietary cholesterol and chylomicrons, which are composed of 82% of TGs. The chylomicrons are transported to fat tissues, where they are stored primarily in the form of neutral lipids [<xref rid="B8-nutrients-12-03859" ref-type="bibr">8</xref>]. TGs play an essential role as a source of energy, such as for the muscles, and they are stored in the adipose tissue [<xref rid="B9-nutrients-12-03859" ref-type="bibr">9</xref>]. Obesity can result if the storage of TGs increases by more than a certain amount through an excessive ingestion of animal fat, which leads to an increased risk and higher incidence of cardiovascular diseases, such as myocardial infarction and arteriosclerosis [<xref rid="B10-nutrients-12-03859" ref-type="bibr">10</xref>]. Therefore, hyperlipidemia and hypertriglyceridemia are risk factors for arteriosclerosis and coronary artery diseases [<xref rid="B11-nutrients-12-03859" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-12-03859" ref-type="bibr">12</xref>]. In this regard, this investigation sought to evaluate whether the extract of roasted Nelumbinis folium (RN) could reduce hypertriglyceridemia.</p><p><italic>Nelumbinis folium</italic> (RN) is the lotus leaf, which is known to have the following effects: cooling of heat, smoothing of the metabolism of water in the body, clearing the blood, and removing the extravasated blood [<xref rid="B13-nutrients-12-03859" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-12-03859" ref-type="bibr">14</xref>,<xref rid="B15-nutrients-12-03859" ref-type="bibr">15</xref>]. Roasted RN is a medicinal substance produced by folding the lotus leaf, placing it in a pot, sealing it with salt-rich mud, pressing it with a heavy object, and heating it to a high temperature. This preparation is known to be used for various hemorrhagic diseases and postpartum bleeding and dizziness owing to its enhanced astringing effect, blood stasis removal, and stopping of bleeding [<xref rid="B16-nutrients-12-03859" ref-type="bibr">16</xref>]. This medicinal preparation is expected to increase the effect of the lotus leaf, but it has not been investigated yet. Therefore, this study was conducted to examine whether the administration of RN could improve metabolic diseases, such as obesity and insulin resistance, caused by high-fat/high-cholesterol diets in rats.</p></sec><sec id="sec2-nutrients-12-03859"><title>2. Materials and Methods</title><sec id="sec2dot1-nutrients-12-03859"><title>2.1. Preparation of Roasted Nelumbinis folium (RN) Component Analysis</title><p>The leaf of roasted <italic>Nelumbinis folium</italic> (RN) herb was purchased from the Herbal Medicine Cooperative Association, Iksan, Jeonbuk, South Korea. The RN (100 g) were boiled with 1 L of distilled water at 100 &#x000b0;C for 2 h. The extract was filtered and centrifuged at 3000 rpm for 20 min at 4 &#x000b0;C. The supernatant was concentrated, and then the RN extract was lyophilized with a freeze dryer. The extract was dried (extract yield: 10.1%) and stored at &#x02212;70 &#x000b0;C. The chemical components of RN were analyzed using ultra-performance liquid chromatography equipped with quadrupole Q exactive Orbitrap mass spectrometry UPLC/QE Orbitrap MS. Details about the UPLC/QE Orbitrap MS analysis of compounds in RN are described in the Materials 1. Additionally, details about identified compounds are listed in <xref ref-type="app" rid="app1-nutrients-12-03859">Table S1</xref>. The extract voucher specimen (No. HBA 162-01) is deposited in the herbarium of the Hanbang Cardio-renal Research Center, Wonkwang University.</p></sec><sec id="sec2dot2-nutrients-12-03859"><title>2.2. Animals and Treatment</title><p>All experiments were performed according to protocols that were approved by the Animal Care Committee of Wonkwang University and by the Institution Animal Care and Use Committee (IACUC) Certification of the Wonkwang University, Korea (WKU16-95). Male Sprague&#x02013;Dawley (SD) rats (8-week-old) were purchased from Samtako (Samtako Bio Korea Inc., Osan, Korea) and used for a total of 13 weeks. The animals were housed in a temperature-controlled environment and maintained on a 12 h dark/12 h light cycle at a temperature of 23 &#x000b0;C &#x000b1; 2 &#x000b0;C and relative humidity of 50&#x02013;60% with free access to laboratory food and water. After a week of adaptation, the SD rats were randomly divided into the following five groups with fifteen rats per group: Control, regular diet (<italic>n</italic> = 12); HFC, HFC diet (<italic>n</italic> = 12); FLU, fluvastatin (3 mg/kg/day, <italic>n</italic> = 10) with HFC diet; RNL, RN (100 mg/kg/day, <italic>n</italic> = 10) with HFC diet; RNH, RN (200 mg/kg/day, <italic>n</italic> = 10) with HFC diet. The control group was fed a regular diet for 13 weeks. The HFC diet group was fed a high-fat, high-cholesterol diet, of which 60% (kcal/kcal) was derived from fat and 22.5% (kcal/kcal) from lard (cat no. D12492, Research Diets, Inc., New Brunswick, NJ, USA). All groups were fed an HFC diet for four weeks, whereas FLU, RNL, and RNH groups were provided an HFC diet for the next nine weeks. Fluvastatin was used as a positive control in this study, since it is a drug used for hyperlipidemia, which acts by reducing cholesterol and TG levels in plasma and decreases fat accumulation in tissues.</p></sec><sec id="sec2dot3-nutrients-12-03859"><title>2.3. Changes in Vascular Tone Relaxation and Systolic Blood Pressure</title><p>Non-invasive blood pressure was measured in all animal groups using the tail cuff CODATM High Throughput System (Kent Scientific Corporation, Torrington, CT, USA). The aortic ring was prepared as previously reported, and a vascular relaxation experiment was performed [<xref rid="B17-nutrients-12-03859" ref-type="bibr">17</xref>]. Changes in the isobaric tension in the thoracic aorta were recorded using a transducer (Grass FT 03, Grass Instrument Co, MA, USA) connected to a Grass Polygraph recording system (Model 7E, Grass Instrument Co, Quincy, MA, USA). After inducing contraction with phenylephrine (1 &#x003bc;M), treatment with acetylcholine (0.3 nM to 3 &#x003bc;M) was performed in a dose-dependent manner to confirm its relaxation effect.</p></sec><sec id="sec2dot4-nutrients-12-03859"><title>2.4. Hematological Analysis</title><p>The blood was collected 13 weeks later as the experiment was completed, and the plasma was obtained via centrifugation at 13,000 rpm for 10 min. Plasma hematological tests to measure the total cholesterol, TGs, glucose, and HDL were performed using an automated clinical chemistry analyzer (FUJI DRI-CHEM NX700, FUJIFILM Corporation, Tokyo, Japan). The levels of fatty acids (ab65341, Abcam Inc., Bristol, UK), fatty acid synthase (CSB-E16440r, Cusabio Biotech Co, Houston, TX, USA), and serum insulin concentration (EIA-2943, DRG Ultra-Sensitive Rat Insulin ELISA, DRG International Inc., Springfield, NJ, USA) were determined using commercially available ELISA kits.</p></sec><sec id="sec2dot5-nutrients-12-03859"><title>2.5. Extraction of RNA and Quantitative Real-Time Polymerase Chain Reaction (qPCR) Analysis</title><p>The total RNA of the liver tissue was extracted using TRIzol reagent (Ambion, Carlsbad, CA, USA), and the cDNA was synthesized using a cDNA kit (Applied Biosystems, Waltham, MA, USA) according to the manufacturer&#x02019;s recommendations. The samples were analyzed using SYBR Green PCR Master Mix (Applied Biosystems) through a quantitative real-time polymerase chain reaction. The sequences of primers used in this experiment were as followed: LXR-1, sense: 5&#x02032;-GAAGAAACTGAAGCCGCAAG-3&#x02032;, anti-sense: 5&#x02032;-TAGCATCCGTGG3AACATCA-3&#x02032;; SREBP-1c, sense: 5&#x02032;-GGTTTTCAACGACAT CGAAGA-3&#x02032;, anti-sense: 5&#x02032;-CGGGAAGTC ACT3TCTTGGT-3&#x02032;; GAPDH, sense: 50-CGA GAA TGG GAA GCT TGT CAT C-30, anti-sense: 50-CGG CCT CAC CCC ATT TG-30. The PCR was started at 95 &#x000b0;C for 15 min (hot start) to activate the AmpliTaq polymerase, followed by a 45-cycle amplification; denaturation at 94 &#x000b0;C for 20 s, annealing at 60 &#x000b0;C for 30 s, extension at 72 &#x000b0;C for 60 s, and plate reading at 60 &#x000b0;C for 10 s. The temperature of PCR products was elevated from 65 to 95 &#x000b0;C at a rate of 0.2 &#x000b0;C/1 s, and the analysis of gene expression was conducted by Step One Plus Real-Time PCR system (Applied Biosystems).</p></sec><sec id="sec2dot6-nutrients-12-03859"><title>2.6. Concentration of Hepatic TGs</title><p>Liver tissue was homogenized in phosphate-buffered saline, and lipids were extracted using a chloroform&#x02013;methanol (2:1) mixture. Liver TG levels in 50 mg of liver tissue were determined according to the method by Bligh and Dyer [<xref rid="B18-nutrients-12-03859" ref-type="bibr">18</xref>] and quantified using an enzymatic assay (Roche Diagnostics, Rotkreuz, Switzerland).</p></sec><sec id="sec2dot7-nutrients-12-03859"><title>2.7. Histopathological Staining of Tissues</title><p>The collected thoracic aorta tissues were fixed for three days in 10% formalin (pH 7.4) and washed with water to remove the remaining formalin from tissues. The paraffin blocks were sectioned in 6&#x02013;7-&#x003bc;m slices using a microtome (Thermo Electron Corporation, Pittsburg, PA, USA).</p><p>Liver and epididymal fat tissues were fixed by immersion in 4% paraformaldehyde for two days at 4 &#x000b0;C and then incubated with 30% sucrose for two days. The frozen sections were cut using a Shandon Cryotome SME (Thermo Electron Corporation, Pittsburg, PA, USA). The slides were stained with hematoxylin and eosin (H&#x00026;E) and oil red O staining for histopathological studies and observed using light microscopy (EVOSTM M5000, Thermo Fisher Scientific, Bothell, WA, USA).</p></sec><sec id="sec2dot8-nutrients-12-03859"><title>2.8. Statistical Analysis</title><p>The data are expressed as mean &#x000b1; standard error. Differences between the mean values were analyzed using the Student&#x02019;s <italic>t</italic>-test by using SigmaPlot version 10. Differences between groups were considered significant at <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="sec3-nutrients-12-03859"><title>3. Results</title><sec id="sec3dot1-nutrients-12-03859"><title>3.1. Analysis of the Components of Roasted RN</title><p>The known components of RN were verified by comparison with 9 pure compounds, namely, (+)-catechin, 4-hydroxycinnamic acid, 5-hydroxymethylfurfural, epicatechin, glycyrrhizin, liquiritin apioside, myricetin, protocatechuic acid, and rutin. Based on the retention time, mass spectroscopy, and MS/MS fragmentation patterns, among others, six components of RN were tentatively identified as adenosine, isoquercitrin, quercetin-4&#x02032;-glucoside, threonic acid, trigonelline, and valine (<xref ref-type="fig" rid="nutrients-12-03859-f001">Figure 1</xref>). In particular, the protocatechuic acid and rutin has been identified as a major bioactive compound of the RN.</p></sec><sec id="sec3dot2-nutrients-12-03859"><title>3.2. Effect of RN on Body and Tissue Weight Changes in High Fat/Cholesterol Diet Fed Rats</title><p>The effects of RN on the body weight were compared between groups after providing a regular diet and a high fat/cholesterol (HFC) diet for 10 weeks. The body weight at the beginning of the experiment was not significantly different among the groups. The weight at the end of the experiment showed a significant increase of 10.9% (<italic>p</italic> &#x0003c; 0.05) in rats in the group fed an HFC diet compared to those in the control group, but a significant decrease of 7.1% (<italic>p</italic> &#x0003c; 0.05) was observed in the rats in the RN group. The weight of epididymal adipose tissue, liver, and heart of rats in the HFC diet group was significantly increased compared to that in the control group but was decreased in the RN-treated group. There was no significant difference in the weight of the kidneys among groups (<xref rid="nutrients-12-03859-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3dot3-nutrients-12-03859"><title>3.3. Effects of RN on Vascular Dysfunction in HFC Diet Rats</title><p>After 11 weeks of dietary intervention, the systolic blood pressure was found to be significantly higher in rats in the HFC diet-fed group than those in the control group. On the other hand, the RN-treated HFC diet rats had a significantly lower systolic blood pressure than those in the HFC diet group (<xref ref-type="fig" rid="nutrients-12-03859-f002">Figure 2</xref>A). The improvement in vascular reactivity by RN in the HFC diet-fed rats was confirmed using isolated aortic rings. Our findings indicated that acetylcholine-induced endothelial-dependent vascular relaxation, which was significantly weakened in HFC diet rats (73.89 &#x000b1; 3.46%, <italic>p</italic> &#x0003c; 0.001 vs. CON), significantly recovered after RN treatment (<xref ref-type="fig" rid="nutrients-12-03859-f002">Figure 2</xref>B). The vessel thickness was measured using hematoxylin and eosin staining to evaluate the effect of vascular morphological changes. The thoracic aortic tissue showed a thickening of the blood vessels in the HFC diet rats, which was improved by RN treatment (<xref ref-type="fig" rid="nutrients-12-03859-f002">Figure 2</xref>C). These results suggested that RN administration could ameliorate vascular dysfunction in rats fed an HFC diet.</p></sec><sec id="sec3dot4-nutrients-12-03859"><title>3.4. Effect of RN on Hematological Changes in HFC Diet-Fed Rats</title><p>The levels of insulin, glucose, TG, total cholesterol (T-Cho), and low-density lipoprotein (LDL) were higher in the HFC diet group compared to those in the control group. However, the administration of RN decreased these responses (<xref ref-type="fig" rid="nutrients-12-03859-f003">Figure 3</xref>C). Moreover, high-density lipoprotein (HDL) levels were significantly increased in the group administered RN (<xref ref-type="fig" rid="nutrients-12-03859-f003">Figure 3</xref>C). In addition, fluvastatin lowered total cholesterol, LDL cholesterol, and triglycerides in the blood, and RN treatment was as effective as a known positive control. TGs are converted into free fatty acids (FFAs) through hydrolysis and are secreted in the blood, which is then transported to the muscles or liver. Therefore, the levels of FFAs and fatty acid synthase (FAS) were measured (<xref ref-type="fig" rid="nutrients-12-03859-f003">Figure 3</xref>D). Rats in the HFC diet-fed group were found to have increased levels of FAS and FFAs compared to those in the regular diet group, while those in the RN treatment group had decreased levels, which showed an improvement in TG production in the blood.</p></sec><sec id="sec3dot5-nutrients-12-03859"><title>3.5. Effect of RN on Changes in the Size of Epididymal Adipocytes in HFC Diet Rats</title><p>The abdominal fat areas were marked with red lines and compared by groups, the areas of abdominal fat increased in HFC diet rats, and treatment of RN reduced the abdominal fat area (<xref ref-type="fig" rid="nutrients-12-03859-f004">Figure 4</xref>A). RN administration significantly reduced the weight of epididymal adipose tissue in HFC diet-fed rats (<xref ref-type="fig" rid="nutrients-12-03859-f004">Figure 4</xref>C). Therefore, to observe changes in the size of the adipocytes, oil red O staining of epididymal adipose tissue was performed (<xref ref-type="fig" rid="nutrients-12-03859-f004">Figure 4</xref>B,D). Therefore, it was confirmed that the size and amount of fat increased by the HFC diet were reduced by RN treatment.</p></sec><sec id="sec3dot6-nutrients-12-03859"><title>3.6. Effect of RN on Liver Function and Hepatic Lipids in HFC Diet-Fed Rats</title><p>To investigate the accumulation of fat in the liver of the rats in each group, sections of the liver were prepared using the frozen samples, and oil red O staining was performed. The results indicated that liver lipids were detected in HFC diet-fed rats, and the group treated with RN showed a decrease (<italic>p</italic> &#x0003c; 0.01) in lipid distribution in the liver compared to the HFC diet-fed group (<xref ref-type="fig" rid="nutrients-12-03859-f005">Figure 5</xref>A). In particular, treatment with RNH more effectively suppressed lipid accumulation. A similar trend was observed in liver TG levels (<xref ref-type="fig" rid="nutrients-12-03859-f005">Figure 5</xref>B). The aspartate aminotransferase (AST)/alanine aminotransferse (ALT) ratio is an indicator of hepatic cell damage and is frequently used to determine liver function. The effect on the reduction of the AST/ALT ratio was significant in the RNL group, while the decrease in the FLU group (<italic>p</italic>-value of 0.0581) was not significant (<xref ref-type="fig" rid="nutrients-12-03859-f005">Figure 5</xref>C). To investigate the role of genes regulating the synthesis of triglycerides in HFC diet rats, real-time PCR was conducted using liver-tissue samples. HFC diet induced the expression of <italic>LXR</italic> and <italic>SREBP-1</italic>, which are associated with lipogenesis, biosynthesis of fatty acids, and the maturation of triglycerides. The administration of RN significantly reduced the gene expression of both <italic>LXR</italic> and <italic>SREBP-1</italic>. In FLU groups, LXR (<italic>p</italic>-value of 0.060) and SREBP-1 (<italic>p</italic>-value of 0.054) showed a decrease in gene expression levels, but it was not significant (<xref ref-type="fig" rid="nutrients-12-03859-f005">Figure 5</xref>D), which indicated the inhibitory effect of RN on the biosynthesis of triglycerides. These results suggested that the RN could regulate TG levels.</p></sec></sec><sec sec-type="discussion" id="sec4-nutrients-12-03859"><title>4. Discussion</title><p>Various studies have reported that HFC diet-fed animals develop abnormal lipid metabolism, hypertriglyceridemia, obesity, glucose tolerance disorders, metabolic syndrome, atherogenic dyslipidemia, and cardiovascular diseases [<xref rid="B19-nutrients-12-03859" ref-type="bibr">19</xref>,<xref rid="B20-nutrients-12-03859" ref-type="bibr">20</xref>,<xref rid="B21-nutrients-12-03859" ref-type="bibr">21</xref>]. In this study, rats that consumed an HFC diet developed hypertriglyceridemia. Moreover, the current investigation sought to verify whether roasted RN could alleviate or reverse hypertriglyceridemia induced by an HFC diet in rats.</p><p>Previous studies indicate that RN has anti-insomnia, anti-anxiety, anti-melanin production [<xref rid="B22-nutrients-12-03859" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-12-03859" ref-type="bibr">23</xref>], antidepressant [<xref rid="B24-nutrients-12-03859" ref-type="bibr">24</xref>], anti-obesity, antioxidant, anti-cardiovascular disease, and anti-cancer effects [<xref rid="B25-nutrients-12-03859" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-12-03859" ref-type="bibr">26</xref>]. Lotus leaf is a traditional medicinal ingredient that has been used for hundreds of years and is widely used as medicines and food. In the case of RN, there is only an example of its production, but its efficacy is still unknown. We compared the relaxation effect of the roasted versus unroasted RN and confirmed that roasted RN had a better effect; then, we examined its effect by selecting an RN (<xref ref-type="app" rid="app1-nutrients-12-03859">Figure S1</xref>). Fluvastatin, a drug used in the management of hyperlipidemia, was used as a positive control to reduce cholesterol, neutral fats in the plasma, and lipid accumulation in the liver [<xref rid="B27-nutrients-12-03859" ref-type="bibr">27</xref>]. The difference in organ and fat weight between animals treated with HFC and those untreated is one of the most important pieces of evidence obtained from morphological comparisons [<xref rid="B28-nutrients-12-03859" ref-type="bibr">28</xref>]. Additionally, the weight of organs and fat, especially the liver, is an essential factor in understanding obesity caused by an HFC diet [<xref rid="B29-nutrients-12-03859" ref-type="bibr">29</xref>]. The HFC diet resulted in an increase in the weight of organs, especially the liver, and was confirmed to be reversed after RN administration. Moreover, an HFC diet is known to cause obesity, and the size of fat cells also increases significantly [<xref rid="B30-nutrients-12-03859" ref-type="bibr">30</xref>,<xref rid="B31-nutrients-12-03859" ref-type="bibr">31</xref>]. Observation of abdominal fat resulted in a significant decrease in the distribution of abdominal fat, which had been increased by the HFC diet, and by reducing epididymal fat pad, the anti-obesity effect of RN could be confirmed.</p><p>Triglycerides (TG) are a major energy source, except for the brain and red blood cells. The liver plays an important role in the synthesis and transport of TGs. However, there are more problems than benefits if TGs are produced in excess [<xref rid="B32-nutrients-12-03859" ref-type="bibr">32</xref>]. In addition, the in vivo lipid imbalance caused by HFC diets increases the concentration of plasma lipoprotein LDL cholesterol and reduces the HDL cholesterol levels, leading to cardiovascular diseases, such as hypertension and arteriosclerosis [<xref rid="B33-nutrients-12-03859" ref-type="bibr">33</xref>,<xref rid="B34-nutrients-12-03859" ref-type="bibr">34</xref>]. Therefore, in hypertriglyceridemia induced by an HFC diet, RN intake can be useful in the treatment of cardiovascular diseases, as it can decrease TG, LDL, and HDL levels [<xref rid="B32-nutrients-12-03859" ref-type="bibr">32</xref>,<xref rid="B33-nutrients-12-03859" ref-type="bibr">33</xref>]. The TGs produce free fatty acids (FFAs) through hydrolysis reactions and are secreted into the blood, which move to the muscles or liver [<xref rid="B35-nutrients-12-03859" ref-type="bibr">35</xref>]. Plasma FFA levels are controlled by FFA distribution between the plasma and adipose tissues and are mediated by lipoprotein lipase and hormone-sensitive lipase [<xref rid="B36-nutrients-12-03859" ref-type="bibr">36</xref>]. The induced FFAs increase neutral fat synthesis in the liver as well as the secretion of very-low-density lipoprotein (VLDL) [<xref rid="B37-nutrients-12-03859" ref-type="bibr">37</xref>,<xref rid="B38-nutrients-12-03859" ref-type="bibr">38</xref>]. Therefore, the levels of FAS and FFAs in the blood were measured and were found to be increased in the rats fed an HFC diet compared to those fed a regular diet; RN could reverse this effect. These findings suggest that RN plays an important role in regulating plasma FFA levels.</p><p>Hypertriglyceridemia is an independent risk factor for coronary artery disease [<xref rid="B39-nutrients-12-03859" ref-type="bibr">39</xref>,<xref rid="B40-nutrients-12-03859" ref-type="bibr">40</xref>] and is known to contribute to arteriosclerosis and coronary artery disease development [<xref rid="B41-nutrients-12-03859" ref-type="bibr">41</xref>]. Moreover, several studies have demonstrated that hypertriglyceridemia can impair endothelial function and thus can affect blood pressure and vasodilation [<xref rid="B42-nutrients-12-03859" ref-type="bibr">42</xref>,<xref rid="B43-nutrients-12-03859" ref-type="bibr">43</xref>]. In addition, systolic dysfunction is reported to be caused by dietary metabolic syndrome and increased contractile dysfunction [<xref rid="B44-nutrients-12-03859" ref-type="bibr">44</xref>]. Vascular dilations in the blood vessels induced by acetylcholine have proved that the endothelium is damaged as a result of the HFC diet, thereby bringing about fluctuations in blood pressure. On the other hand, the reduction in aortic ring relaxation and increase in blood pressure due to acetylcholine were significantly improved by treatment with RN. Therefore, RN is considered to improve vascular dysfunction. In the case of obesity, when fat accumulates in hepatocytes owing to dyslipidemia, liver weight increases and the entire liver becomes enlarged, resulting in further liver damage [<xref rid="B45-nutrients-12-03859" ref-type="bibr">45</xref>,<xref rid="B46-nutrients-12-03859" ref-type="bibr">46</xref>]. In particular, treatment with RN effectively suppressed lipid accumulation and lowered liver TGs.</p><p>Since the synthesis and breakdown of TGs in hypertriglyceridemia occurs in the liver, it is important to check the levels of liver enzymes, including ALT and AST, to determine the degree of liver damage. Hypertriglyceridemia is correlated with abnormal liver function and indicators, such as ALT and AST, can be used to determine the extent of liver damage [<xref rid="B47-nutrients-12-03859" ref-type="bibr">47</xref>]. Results from this study confirmed that RN improved the ALT/AST ratio in HFC diet rats. In hypertriglyceridemia induced by the HFC diet, the RN administration decreased the concentration of ALT and AST, indicating that the HFC diet caused severe damage to the hepatic tissue and that the administration of RN could alleviate liver damage caused by hypertriglyceridemia.</p><p>Additionally, in this study, the liver and blood were examined to determine whether RN affected the accumulation and synthesis of TGs following the HFC diet. <italic>LXR</italic>&#x003b1; and <italic>SREBP-1</italic> are transcription factors that play an important role in the synthesis of TGs in the liver. LXR activation increases TG synthesis and hepatic TG secretion [<xref rid="B48-nutrients-12-03859" ref-type="bibr">48</xref>,<xref rid="B49-nutrients-12-03859" ref-type="bibr">49</xref>]. Moreover, the hepatic regulation of SREBP-1c in fatty acid synthesis leads to an increase in TG levels and promotes VLDL production [<xref rid="B50-nutrients-12-03859" ref-type="bibr">50</xref>,<xref rid="B51-nutrients-12-03859" ref-type="bibr">51</xref>]. Following an HFC diet, LXR increases the expression of SREBP-1, which is a precursor of fatty acids and TGs, resulting in the accumulation of TGs in the liver tissue [<xref rid="B52-nutrients-12-03859" ref-type="bibr">52</xref>]. The administration of RN inhibited the accumulation of TGs, indicating its efficacy in reversing hypertriglyceridemia. <xref ref-type="fig" rid="nutrients-12-03859-f006">Figure 6</xref> shows a schematic image of RN treatment for improving liver dysfunction in hypertriglyceridemia.</p><p>However, it is necessary to acknowledge and resolve the two major limitations of current research. First, unfortunately, separate chemical compounds, such as protocatechuic acid and rutin, have been analyzed for RN, but related studies have not been conducted. Second, our results showed that the hypertriglyceridemia improvement effect of RN was not concentration-dependent and could not be clearly explained, because it was at a similar level or showed only a slight difference in high dosage. Therefore, further studies are necessary to confirm the effect of RN concentration-specific and chemical compounds.</p></sec><sec sec-type="conclusions" id="sec5-nutrients-12-03859"><title>5. Conclusions</title><p>In this study, the administration of RN resulted in an improvement in overall lipid metabolism and a decrease in the concentration of triglycerides in a rat model of HFC diet-induced hypertriglyceridemia. In particular, inhibiting the production of TGs by RN was found to be related to the inhibition of triglyceride synthesis by inhibiting LXR activity. Therefore, the results of our study suggest that RN has the potential to be used in the treatment of hypertriglyceridemia.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-nutrients-12-03859"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/2072-6643/12/12/3859/s1">https://www.mdpi.com/2072-6643/12/12/3859/s1</uri>, Figure S1: Dose-dependent vascular relaxation effect of roasted and non-roasted <italic>Nelumbinis folium</italic> in thoracic aortic rings; Materials 1. UPLC/QE Orbitrap MS analysis of Compounds in roasted <italic>Nelumbinis folium</italic> (RN); Table S1. List of identified compounds in roasted <italic>Nelumbinis folium</italic> (RN).</p><supplementary-material content-type="local-data" id="nutrients-12-03859-s001"><media xlink:href="nutrients-12-03859-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>H.S.L. and D.G.K. (important discussion, comments), and H.Y.K. conceived the study and designed the experiments. J.E.L. contributed to sample validation [material]. H.Y.K. and M.H.H. performed the experiments. H.Y.K., J.J.Y. and M.H.H. analyzed the data. H.Y.K. and D.G.K. prepared the figures. H.Y.K., K.W.K. and H.S.L. wrote the main text. H.S.L. and D.G.K. Interpreted the results and revised the manuscript. All authors have reviewed the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by the National Research Foundation of Korea (NRF). NRF-2017R1A5A2015805 to H.S.L. and D.G.K.; NRF-2019R1I1A3A01062432 to H.Y.K.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare they have no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-12-03859"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu&#x0021b;anu</surname><given-names>A.</given-names></name><name><surname>Iancu</surname><given-names>M.</given-names></name><name><surname>Maier</surname><given-names>S.</given-names></name><name><surname>B&#x00103;la&#x0015f;a</surname><given-names>R.</given-names></name><name><surname>Dobreanu</surname><given-names>M.</given-names></name></person-group><article-title>Plasma Biomarkers as Potential Predictors of Functional Dependence in Daily Life Activities after Ischemic Stroke: A Single Center Study</article-title><source>Ann. Indian Acad. Neurol.</source><year>2020</year><volume>23</volume><fpage>496</fpage><lpage>503</lpage><?supplied-pmid 33223667?><pub-id pub-id-type="pmid">33223667</pub-id></element-citation></ref><ref id="B2-nutrients-12-03859"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pol</surname><given-names>T.</given-names></name><name><surname>Held</surname><given-names>C.</given-names></name><name><surname>Westerbergh</surname><given-names>J.</given-names></name><name><surname>Lindb&#x000e4;ck</surname><given-names>J.</given-names></name><name><surname>Alexander</surname><given-names>J.H.</given-names></name><name><surname>Alings</surname><given-names>M.</given-names></name><name><surname>Erol</surname><given-names>C.</given-names></name><name><surname>Goto</surname><given-names>S.</given-names></name><name><surname>Halvorsen</surname><given-names>S.</given-names></name><name><surname>Huber</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Dyslipidemia and Risk of Cardiovascular Events in Patients with Atrial Fibrillation Treated with Oral Anticoagulation Therapy: Insights from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial</article-title><source>J. Am. Heart Assoc.</source><year>2018</year><volume>7</volume><fpage>e007444</fpage><pub-id pub-id-type="doi">10.1161/JAHA.117.007444</pub-id><pub-id pub-id-type="pmid">29419390</pub-id></element-citation></ref><ref id="B3-nutrients-12-03859"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroor</surname><given-names>M.M.</given-names></name><name><surname>Sennels</surname><given-names>H.P.</given-names></name><name><surname>Fahrenkrug</surname><given-names>J.</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>H.L.</given-names></name><name><surname>Plat</surname><given-names>J.</given-names></name><name><surname>Mensink</surname><given-names>R.P.</given-names></name><name><surname>Schroor</surname><given-names>M.M.</given-names></name></person-group><article-title>Diurnal Variation of Markers for Cholesterol Synthesis, Cholesterol Absorption, and Bile Acid Synthesis: A Systematic Review and the Bispebjerg Study of Diurnal Variations</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>1439</elocation-id><pub-id pub-id-type="doi">10.3390/nu11071439</pub-id><?supplied-pmid 31247945?><pub-id pub-id-type="pmid">31247945</pub-id></element-citation></ref><ref id="B4-nutrients-12-03859"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2017 Causes of Death Collaborators</collab></person-group><article-title>Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980&#x02013;2017: A systematic analysis for the Global Burden of Disease Study 2017</article-title><source>Lancet</source><year>2018</year><volume>392</volume><fpage>1736</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)32203-7</pub-id><pub-id pub-id-type="pmid">30496103</pub-id></element-citation></ref><ref id="B5-nutrients-12-03859"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sniderman</surname><given-names>A.D.</given-names></name><name><surname>Couture</surname><given-names>P.</given-names></name><name><surname>Martin</surname><given-names>S.S.</given-names></name><name><surname>DeGraaf</surname><given-names>J.</given-names></name><name><surname>Lawler</surname><given-names>P.R.</given-names></name><name><surname>Cromwell</surname><given-names>W.C.</given-names></name><name><surname>Wilkins</surname><given-names>J.T.</given-names></name><name><surname>Thanassoulis</surname><given-names>G.</given-names></name></person-group><article-title>Hypertriglyceridemia and cardiovascular risk: A cautionary note about metabolic confounding</article-title><source>J. Lipid. Res.</source><year>2018</year><volume>59</volume><fpage>1266</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.1194/jlr.R082271</pub-id><?supplied-pmid 29769239?><pub-id pub-id-type="pmid">29769239</pub-id></element-citation></ref><ref id="B6-nutrients-12-03859"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varbo</surname><given-names>A.</given-names></name><name><surname>Nordestgaard</surname><given-names>B.G.</given-names></name></person-group><article-title>Remnant cholesterol and ischemic heart disease</article-title><source>Curr. Opin. Lipidol.</source><year>2014</year><volume>25</volume><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1097/MOL.0000000000000093</pub-id><pub-id pub-id-type="pmid">24977981</pub-id></element-citation></ref><ref id="B7-nutrients-12-03859"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>L.</given-names></name><name><surname>Martin</surname><given-names>N.</given-names></name><name><surname>Jimoh</surname><given-names>O.F.</given-names></name><name><surname>Kirk</surname><given-names>C.</given-names></name><name><surname>Foster</surname><given-names>E.</given-names></name><name><surname>Abdelhamid</surname><given-names>A.S.</given-names></name></person-group><article-title>Reduction in saturated fat intake for cardiovascular disease</article-title><source>Cochrane Database Syst. Rev.</source><year>2020</year><volume>5</volume><fpage>CD011737</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD011737</pub-id><pub-id pub-id-type="pmid">32428300</pub-id></element-citation></ref><ref id="B8-nutrients-12-03859"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.W.</given-names></name><name><surname>Yang</surname><given-names>M.Y.</given-names></name><name><surname>Hung</surname><given-names>T.W.</given-names></name><name><surname>Chang</surname><given-names>Y.C.</given-names></name><name><surname>Wang</surname><given-names>C.J.</given-names></name></person-group><article-title><italic>Nelumbo nucifera</italic> leaves extract attenuate the pathological progression of diabetic nephropathy in high-fat diet-fed and streptozotocin-induced diabetic rats</article-title><source>J. Food Drug Anal.</source><year>2019</year><volume>27</volume><fpage>736</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1016/j.jfda.2018.12.009</pub-id><pub-id pub-id-type="pmid">31324289</pub-id></element-citation></ref><ref id="B9-nutrients-12-03859"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.A.</given-names></name></person-group><article-title>Triglyceride and Cardiovascular Disease</article-title><source>J. Lipid Atheroscler.</source><year>2013</year><volume>2</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.12997/jla.2013.2.1.1</pub-id></element-citation></ref><ref id="B10-nutrients-12-03859"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lum-Naihe</surname><given-names>K.</given-names></name><name><surname>Toedebusch</surname><given-names>R.</given-names></name><name><surname>Mahmood</surname><given-names>A.</given-names></name><name><surname>Bajwa</surname><given-names>J.</given-names></name><name><surname>Carmack</surname><given-names>T.</given-names></name><name><surname>Kumar</surname><given-names>S.A.</given-names></name><name><surname>Ardhanari</surname><given-names>S.</given-names></name><name><surname>DeMarco</surname><given-names>V.G.</given-names></name><name><surname>Emter</surname><given-names>C.A.</given-names></name><name><surname>Pulakat</surname><given-names>L.</given-names></name></person-group><article-title>Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>17823</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-18003-8</pub-id><pub-id pub-id-type="pmid">29259233</pub-id></element-citation></ref><ref id="B11-nutrients-12-03859"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloska</surname><given-names>A.</given-names></name><name><surname>Malinowska</surname><given-names>M.</given-names></name><name><surname>Gabig-Cimi&#x00144;ska</surname><given-names>M.</given-names></name><name><surname>Jak&#x000f3;bkiewicz-Banecka</surname><given-names>J.</given-names></name></person-group><article-title>Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>3618</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21103618</pub-id><?supplied-pmid 32443889?><pub-id pub-id-type="pmid">32443889</pub-id></element-citation></ref><ref id="B12-nutrients-12-03859"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabana</surname></name><name><surname>Shahid</surname><given-names>S.U.</given-names></name><name><surname>Sarwar</surname><given-names>S.</given-names></name></person-group><article-title>The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects</article-title><source>Lipids Health Dis.</source><year>2020</year><volume>19</volume><fpage>73</fpage><pub-id pub-id-type="doi">10.1186/s12944-020-01248-0</pub-id><?supplied-pmid 32290855?><pub-id pub-id-type="pmid">32290855</pub-id></element-citation></ref><ref id="B13-nutrients-12-03859"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Xie</surname><given-names>B.</given-names></name><name><surname>Ran</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name></person-group><article-title>The anti-obesity efect of lotus leaves on high-fat-diet-induced obesity by modulating lipid metabolism in C57BL/6J mice</article-title><source>Appl. Biol. Chem.</source><year>2020</year><volume>63</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s13765-020-00541-x</pub-id></element-citation></ref><ref id="B14-nutrients-12-03859"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>J.S.</given-names></name><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Chang</surname><given-names>K.J.</given-names></name></person-group><article-title>Ethanol extract of lotus (<italic>Nelumbo nucifera</italic>) root exhibits an anti-adipogenic effect in human pre-adipocytes and anti-obesity and anti-oxidant effects in rats fed a high-fat diet</article-title><source>Nutr. Res.</source><year>2014</year><volume>34</volume><fpage>258</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2014.01.003</pub-id><pub-id pub-id-type="pmid">24655493</pub-id></element-citation></ref><ref id="B15-nutrients-12-03859"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>L.H.</given-names></name><name><surname>He</surname><given-names>X.X.</given-names></name><name><surname>Kong</surname><given-names>L.T.</given-names></name><name><surname>Liao</surname><given-names>Y.H.</given-names></name><name><surname>Pan</surname><given-names>R.L.</given-names></name><name><surname>Xiao</surname><given-names>B.X.</given-names></name><name><surname>Liu</surname><given-names>X.M.</given-names></name><name><surname>Chang</surname><given-names>Q.</given-names></name></person-group><article-title>Identification and characterization of potent CYP2D6 inhibitors in lotus leaves</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>153</volume><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.02.014</pub-id><pub-id pub-id-type="pmid">24561383</pub-id></element-citation></ref><ref id="B16-nutrients-12-03859"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lia</surname><given-names>L.</given-names></name><name><surname>Shu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.R.</given-names></name><name><surname>Yang</surname><given-names>S.L.</given-names></name><name><surname>Hao</surname><given-names>L.L.</given-names></name></person-group><article-title>Studies of burnt <italic>Folium Nelumbinis</italic> in anastalsis and processing</article-title><source>J. Chin. Med. Mater.</source><year>2010</year><volume>33</volume><fpage>1852</fpage><lpage>1855</lpage></element-citation></ref><ref id="B17-nutrients-12-03859"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Oh</surname><given-names>H.C.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Cho</surname><given-names>K.W.</given-names></name><name><surname>Kang</surname><given-names>D.G.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name></person-group><article-title>Ethanol extract of seeds of Oenotheraodorata induces vasorelaxation via endothelium-dependent NO-cGMP signaling through activation of Akt-eNOS-sGC pathway</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>133</volume><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.09.024</pub-id><pub-id pub-id-type="pmid">20932888</pub-id></element-citation></ref><ref id="B18-nutrients-12-03859"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavonius</surname><given-names>L.R.</given-names></name><name><surname>Carlsson</surname><given-names>N.G.</given-names></name><name><surname>Undeland</surname><given-names>I.</given-names></name></person-group><article-title>Quantification of total fatty acids in microalgae: Comparison of extraction and transesterification methods</article-title><source>Anal. Bioanal. Chem.</source><year>2014</year><volume>406</volume><fpage>7313</fpage><lpage>7322</lpage><pub-id pub-id-type="doi">10.1007/s00216-014-8155-3</pub-id><pub-id pub-id-type="pmid">25224639</pub-id></element-citation></ref><ref id="B19-nutrients-12-03859"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hariri</surname><given-names>N.</given-names></name><name><surname>Thibault</surname><given-names>L.</given-names></name></person-group><article-title>High-fat diet-induced obesity in animal models</article-title><source>Nutr. Res. Rev.</source><year>2010</year><volume>23</volume><fpage>270</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1017/S0954422410000168</pub-id><pub-id pub-id-type="pmid">20977819</pub-id></element-citation></ref><ref id="B20-nutrients-12-03859"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrie</surname><given-names>J.R.</given-names></name><name><surname>Guzik</surname><given-names>T.J.</given-names></name><name><surname>Touyz</surname><given-names>R.M.</given-names></name></person-group><article-title>Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms</article-title><source>Can. J. Cardiol.</source><year>2018</year><volume>34</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/j.cjca.2017.12.005</pub-id><pub-id pub-id-type="pmid">29459239</pub-id></element-citation></ref><ref id="B21-nutrients-12-03859"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Al Qarni</surname><given-names>A.</given-names></name><name><surname>Hawwari</surname><given-names>A.</given-names></name><name><surname>Alghanem</surname><given-names>A.F.</given-names></name><name><surname>Ahmed</surname><given-names>G.</given-names></name></person-group><article-title>Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism</article-title><source>Curr. Diabetes Rev.</source><year>2018</year><volume>14</volume><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.2174/1573399813666170705161039</pub-id><?supplied-pmid 28677496?><pub-id pub-id-type="pmid">28677496</pub-id></element-citation></ref><ref id="B22-nutrients-12-03859"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sang</surname><given-names>M.</given-names></name><name><surname>Du</surname><given-names>G.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name></person-group><article-title>Modeling and optimizing inhibitory activities of <italic>Nelumbinis folium</italic> extract on xanthine oxidase using response surface methodology</article-title><source>J. Pharm. Biomed. Anal.</source><year>2017</year><volume>139</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2017.02.048</pub-id><?supplied-pmid 28273649?><pub-id pub-id-type="pmid">28273649</pub-id></element-citation></ref><ref id="B23-nutrients-12-03859"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Lv</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>B.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name></person-group><article-title><italic>Folium nelumbinis</italic> (Lotus leaf) volatile-rich fraction and its mechanisms of action against melanogenesis in B16 cells</article-title><source>Food Chem.</source><year>2020</year><volume>330</volume><fpage>127030</fpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2020.127030</pub-id><?supplied-pmid 32535311?><pub-id pub-id-type="pmid">32535311</pub-id></element-citation></ref><ref id="B24-nutrients-12-03859"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Shim</surname><given-names>I.S.</given-names></name><name><surname>Bae</surname><given-names>H.S.</given-names></name></person-group><article-title>Assessment of anti-depressant effect of nelumbinis semen on rats under chronic mild stress and its subchronic oral toxicity in rats and beagle dogs</article-title><source>BMC Complement Altern. Med.</source><year>2012</year><volume>12</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-12-68</pub-id><?supplied-pmid 22640371?><pub-id pub-id-type="pmid">22640371</pub-id></element-citation></ref><ref id="B25-nutrients-12-03859"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Ban</surname><given-names>X.Q.</given-names></name><name><surname>He</surname><given-names>J.S.</given-names></name><name><surname>Tong</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.W.</given-names></name></person-group><article-title>Hepatoprotective and antioxidant activity of ethanolic extracts of edible lotus (<italic>Nelumbo nucifera</italic> Gaertn.) leaves</article-title><source>Food Chem.</source><year>2010</year><volume>120</volume><fpage>873</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2009.11.020</pub-id></element-citation></ref><ref id="B26-nutrients-12-03859"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S.</given-names></name><name><surname>Nakashima</surname><given-names>S.</given-names></name></person-group><article-title>Tanabe, GAlkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera) with melanogenesis inhibitory activity in B16 melanoma cells</article-title><source>Bioorganic Med. Chem.</source><year>2013</year><volume>21</volume><fpage>779</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2012.11.038</pub-id></element-citation></ref><ref id="B27-nutrients-12-03859"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>S.P.</given-names></name><name><surname>Sekhon</surname><given-names>S.S.</given-names></name><name><surname>Tsang</surname><given-names>M.</given-names></name><name><surname>Wright</surname><given-names>J.M.</given-names></name></person-group><article-title>Fluvastatin for lowering lipids</article-title><source>Cochrane Database Syst. Rev.</source><year>2018</year><volume>3</volume><fpage>CD012282</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD012282.pub2</pub-id><pub-id pub-id-type="pmid">29508377</pub-id></element-citation></ref><ref id="B28-nutrients-12-03859"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfsegger</surname><given-names>M.J.</given-names></name><name><surname>Jaki</surname><given-names>T.</given-names></name><name><surname>Dietrich</surname><given-names>B.</given-names></name><name><surname>Kunzler</surname><given-names>J.A.</given-names></name><name><surname>Barker</surname><given-names>K.</given-names></name></person-group><article-title>A note on statistical analysis of organ weights in non-clinical toxicological studies</article-title><source>Toxicol. Appl. Pharmacol.</source><year>2009</year><volume>240</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2009.06.012</pub-id><pub-id pub-id-type="pmid">19540255</pub-id></element-citation></ref><ref id="B29-nutrients-12-03859"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.C.</given-names></name><name><surname>Xuan</surname><given-names>D.Y.</given-names></name></person-group><article-title>Impacts of periodontitis on visceral organ weight and weight percentage in obese mice</article-title><source>West China J. Stomatol.</source><year>2018</year><volume>36</volume><fpage>514</fpage><lpage>520</lpage></element-citation></ref><ref id="B30-nutrients-12-03859"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenkula</surname><given-names>K.G.</given-names></name><name><surname>Erlanson-Albertsson</surname><given-names>C.</given-names></name></person-group><article-title>Adipose cell size: Importance in health and disease</article-title><source>Am. J. Physiol. Regul. Integr. Comp. Physiol.</source><year>2018</year><volume>315</volume><fpage>R284</fpage><lpage>R295</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00257.2017</pub-id><pub-id pub-id-type="pmid">29641234</pub-id></element-citation></ref><ref id="B31-nutrients-12-03859"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engin</surname><given-names>A.</given-names></name></person-group><article-title>Fat Cell and Fatty Acid Turnover in Obesity</article-title><source>Adv. Exp. Med. Biol.</source><year>2017</year><volume>960</volume><fpage>135</fpage><lpage>160</lpage><?supplied-pmid 28585198?><pub-id pub-id-type="pmid">28585198</pub-id></element-citation></ref><ref id="B32-nutrients-12-03859"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>P.P.</given-names></name></person-group><article-title>Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease</article-title><source>Vasc. Health Risk Manag.</source><year>2016</year><volume>12</volume><fpage>171</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.2147/VHRM.S104369</pub-id><pub-id pub-id-type="pmid">27226718</pub-id></element-citation></ref><ref id="B33-nutrients-12-03859"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karr</surname><given-names>S.</given-names></name></person-group><article-title>Epidemiology and management of hyperlipidemia</article-title><source>Am. J. Manag. Care</source><year>2017</year><volume>23</volume><fpage>S139</fpage><lpage>S148</lpage><pub-id pub-id-type="pmid">28978219</pub-id></element-citation></ref><ref id="B34-nutrients-12-03859"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkins</surname><given-names>C.</given-names></name><name><surname>Friedrich</surname><given-names>D.</given-names></name></person-group><article-title>Hypertriglyceridemia: A review of the evidence</article-title><source>Nurse Pract.</source><year>2018</year><volume>43</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1097/01.NPR.0000544997.22887.0b</pub-id></element-citation></ref><ref id="B35-nutrients-12-03859"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>I.</given-names></name><name><surname>Inoue</surname><given-names>D.</given-names></name><name><surname>Ichimura</surname><given-names>A.</given-names></name><name><surname>Hirasawa</surname><given-names>A.</given-names></name></person-group><article-title>Free fatty acid receptors and their role in regulation of energy metabolism</article-title><source>Rev. Physiol. Biochem. Pharmacol.</source><year>2013</year><volume>164</volume><fpage>77</fpage><lpage>116</lpage><?supplied-pmid 23625068?><pub-id pub-id-type="pmid">23625068</pub-id></element-citation></ref><ref id="B36-nutrients-12-03859"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcelin</surname><given-names>G.</given-names></name><name><surname>Cl&#x000e9;ment</surname><given-names>K.</given-names></name></person-group><article-title>Adipose tissue fibrosis: An aggravating factor in obesity</article-title><source>Med. Sci.</source><year>2018</year><volume>34</volume><fpage>424</fpage><lpage>431</lpage></element-citation></ref><ref id="B37-nutrients-12-03859"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name></person-group><article-title>Interaction between adipocytes and high-density lipoprotein: New insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis</article-title><source>Lipids Health Dis.</source><year>2019</year><volume>18</volume><fpage>223</fpage><pub-id pub-id-type="doi">10.1186/s12944-019-1170-9</pub-id><pub-id pub-id-type="pmid">31842884</pub-id></element-citation></ref><ref id="B38-nutrients-12-03859"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Wan</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice</article-title><source>Cell Death Dis.</source><year>2019</year><volume>10</volume><fpage>728</fpage><pub-id pub-id-type="doi">10.1038/s41419-019-1969-3</pub-id><pub-id pub-id-type="pmid">31570698</pub-id></element-citation></ref><ref id="B39-nutrients-12-03859"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordestgaard</surname><given-names>B.G.</given-names></name><name><surname>Varbo</surname><given-names>A.</given-names></name></person-group><article-title>Triglycerides and cardiovascular disease</article-title><source>Lancet</source><year>2014</year><volume>384</volume><fpage>626</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)61177-6</pub-id><pub-id pub-id-type="pmid">25131982</pub-id></element-citation></ref><ref id="B40-nutrients-12-03859"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>&#x0017d;.</given-names></name></person-group><article-title>Hypertriglyceridaemia and risk of coronary artery disease</article-title><source>Nat. Rev. Cardiol.</source><year>2017</year><volume>14</volume><fpage>401</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2017.31</pub-id><pub-id pub-id-type="pmid">28300080</pub-id></element-citation></ref><ref id="B41-nutrients-12-03859"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Ruan</surname><given-names>G.</given-names></name><name><surname>Peng</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Hypertriglyceridemia and atherosclerosis</article-title><source>Lipids Health Dis.</source><year>2017</year><volume>16</volume><fpage>233</fpage><pub-id pub-id-type="doi">10.1186/s12944-017-0625-0</pub-id><?supplied-pmid 29212549?><pub-id pub-id-type="pmid">29212549</pub-id></element-citation></ref><ref id="B42-nutrients-12-03859"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>S.</given-names></name><name><surname>Gotoh</surname><given-names>N.</given-names></name><name><surname>Hishinuma</surname><given-names>S.</given-names></name><name><surname>Abe</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Katano</surname><given-names>Y.</given-names></name><name><surname>Ishihata</surname><given-names>A.</given-names></name></person-group><article-title>The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction</article-title><source>Nutrients</source><year>2014</year><volume>6</volume><fpage>1236</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.3390/nu6031236</pub-id><?supplied-pmid 24667131?><pub-id pub-id-type="pmid">24667131</pub-id></element-citation></ref><ref id="B43-nutrients-12-03859"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>S.</given-names></name><name><surname>Chait</surname><given-names>A.</given-names></name></person-group><article-title>Hypertriglyceridemia secondary to obesity and diabetes</article-title><source>Biochim. Biophys. Acta</source><year>2012</year><volume>1821</volume><fpage>819</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2011.10.003</pub-id><?supplied-pmid 22005032?><pub-id pub-id-type="pmid">22005032</pub-id></element-citation></ref><ref id="B44-nutrients-12-03859"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>W.Y.</given-names></name><name><surname>Ward</surname><given-names>L.C.</given-names></name><name><surname>Fong</surname><given-names>C.W.</given-names></name><name><surname>Yap</surname><given-names>W.N.</given-names></name><name><surname>Brown</surname><given-names>L.</given-names></name></person-group><article-title>Anti-inflammatory &#x003b3;- and &#x003b4;-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats</article-title><source>Eur. J. Nutr.</source><year>2017</year><volume>56</volume><fpage>133</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1007/s00394-015-1064-1</pub-id><pub-id pub-id-type="pmid">26446095</pub-id></element-citation></ref><ref id="B45-nutrients-12-03859"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gariani</surname><given-names>K.</given-names></name><name><surname>Ryu</surname><given-names>D.</given-names></name><name><surname>Menzies</surname><given-names>K.J.</given-names></name><name><surname>Yi</surname><given-names>H.S.</given-names></name><name><surname>Stein</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Perino</surname><given-names>A.</given-names></name><name><surname>Lemos</surname><given-names>V.</given-names></name><name><surname>Katsyuba</surname><given-names>E.</given-names></name><name><surname>Jha</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease</article-title><source>J. Hepatol.</source><year>2017</year><volume>66</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2016.08.024</pub-id><pub-id pub-id-type="pmid">27663419</pub-id></element-citation></ref><ref id="B46-nutrients-12-03859"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>C.T.</given-names></name><name><surname>Hsieh</surname><given-names>J.</given-names></name><name><surname>Adeli</surname><given-names>K.</given-names></name><name><surname>Lewis</surname><given-names>G.F.</given-names></name></person-group><article-title>Gut-liver interaction in triglyceride-rich lipoprotein metabolism</article-title><source>Am. J. Physiol. Endocrinol. Metab.</source><year>2011</year><volume>301</volume><fpage>E429</fpage><lpage>E446</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00178.2011</pub-id><pub-id pub-id-type="pmid">21693689</pub-id></element-citation></ref><ref id="B47-nutrients-12-03859"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>D.</given-names></name><name><surname>Bach</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Hmama</surname><given-names>Z.</given-names></name><name><surname>Av-Gay</surname><given-names>Y.</given-names></name></person-group><article-title>Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolarH+-ATPase to inhibit phagosome acidifcation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>19371</fpage><lpage>19376</lpage><pub-id pub-id-type="doi">10.1073/pnas.1109201108</pub-id><pub-id pub-id-type="pmid">22087003</pub-id></element-citation></ref><ref id="B48-nutrients-12-03859"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>Q.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group><article-title>Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease</article-title><source>Biomed. Pharmacother.</source><year>2019</year><volume>113</volume><fpage>108778</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2019.108778</pub-id><pub-id pub-id-type="pmid">30897538</pub-id></element-citation></ref><ref id="B49-nutrients-12-03859"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchgessner</surname><given-names>T.G.</given-names></name><name><surname>Sleph</surname><given-names>P.</given-names></name><name><surname>Ostrowski</surname><given-names>J.</given-names></name><name><surname>Lupisella</surname><given-names>J.</given-names></name><name><surname>Ryan</surname><given-names>C.S.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Fernando</surname><given-names>G.</given-names></name><name><surname>Grimm</surname><given-names>D.</given-names></name><name><surname>Shipkova</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Beneficial and adverse effects of an LXR agonist on human lipid and lipoprotein metabolism and circulating</article-title><source>Cell Metab.</source><year>2016</year><volume>24</volume><fpage>223</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.07.016</pub-id><pub-id pub-id-type="pmid">27508871</pub-id></element-citation></ref><ref id="B50-nutrients-12-03859"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Spann</surname><given-names>N.J.</given-names></name><name><surname>Kaikkonen</surname><given-names>M.U.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Oh</surname><given-names>Y.</given-names></name><name><surname>Fox</surname><given-names>J.N.</given-names></name><name><surname>Bandyopadhyay</surname><given-names>G.</given-names></name><name><surname>Talukdar</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Lagakos</surname><given-names>W.S.</given-names></name></person-group><article-title>NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids</article-title><source>Cell</source><year>2013</year><volume>155</volume><fpage>200</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.08.054</pub-id><pub-id pub-id-type="pmid">24074869</pub-id></element-citation></ref><ref id="B51-nutrients-12-03859"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okazaki</surname><given-names>H.</given-names></name><name><surname>Goldstein</surname><given-names>J.L.</given-names></name><name><surname>Brown</surname><given-names>M.S.</given-names></name><name><surname>Liang</surname><given-names>G.</given-names></name></person-group><article-title>LXR-SREBP-1c-phospholipid transfer protein axis controls very low-density lipoprotein (VLDL) particle size</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>6801</fpage><lpage>6810</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.079459</pub-id><?supplied-pmid 20037162?><pub-id pub-id-type="pmid">20037162</pub-id></element-citation></ref><ref id="B52-nutrients-12-03859"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimano</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>R.</given-names></name></person-group><article-title>SREBP-regulated lipid metabolism: Convergent physiology-divergent pathophysiology</article-title><source>Nat. Rev. Endocrinol.</source><year>2017</year><volume>13</volume><fpage>710</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2017.91</pub-id><?supplied-pmid 28849786?><pub-id pub-id-type="pmid">28849786</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-12-03859-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Analysis of the components of roasted <italic>Nelumbinis folium</italic> (RN). Extracted ion chromatograms (EIC) of UPLC/QE Orbitrap MS analysis of the positive (up) and negative (down) charged molecular ion shows nine major compounds.</p></caption><graphic xlink:href="nutrients-12-03859-g001"/></fig><fig id="nutrients-12-03859-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Systolic blood pressure variation in high fat/high cholesterol (HFC) diet rats for analysis of <italic>Nelumbo nucifera</italic> (RN)-treated cardiovascular functional characteristics (<bold>A</bold>). Effect of RN on vascular relaxation by acetylcholine (Ach) in the thoracic aortic ring and on the relaxation rate at the final acetylcholine dose (<bold>B</bold>). Representative histological images of hematoxylin and eosin (H&#x00026;E) staining and aortic media thickness in the thoracic aorta (<bold>C</bold>). CON, regular diet; HFC, HFC diet; FLU, fluvastatin (3 mg/kg/day) with HFC diet; RNN, RN (100 mg/kg/day) with HFC diet; RNH, RN (200 mg/kg/day) with HFC diet. The values represent the means &#x000b1; standard error. * <italic>p</italic> &#x0003c; 0.05, and ** <italic>p</italic> &#x0003c; 0.01, and *** <italic>p</italic> &#x0003c; 0.001 vs. CON; # <italic>p</italic> &#x0003c; 0.05, ## <italic>p</italic> &#x0003c; 0.01, and ### <italic>p</italic> &#x0003c; 0.001 vs. HFC.</p></caption><graphic xlink:href="nutrients-12-03859-g002"/></fig><fig id="nutrients-12-03859-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Hematological changes in the treatment of roasted <italic>Nelumbo nucifera</italic> (RN) in high fat/cholesterol (HFC) diet Rats. Representative plasma images of HFC diet-fed rats appear turbid compared to those of the control group (<bold>A</bold>). Representative plasma image of HFC diet rats that appear turbid compared to the control group (<bold>A</bold>). Measurements of plasma insulin and glucose (<bold>B</bold>) TG, T-Cho, LDL, and HDL (<bold>C</bold>); FFA and FAS (<bold>D</bold>). CON, regular diet; HFC, HFC diet; FLU, fluvastatin (3 mg/kg/day) with HFC diet; RNN, RN (100 mg/kg/day) with HFC diet; RNH, RN (200 mg/kg/day) with HFC diet; TG, triglyceride; T-Cho, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; FFA, free fatty acid; FAS, fatty acid synthase. The values represent the means &#x000b1; standard error. ** <italic>p</italic>&#x0003c;0.01 and *** <italic>p</italic> &#x0003c; 0.001 vs. CON; # <italic>p</italic> &#x0003c; 0.05, ## <italic>p</italic> &#x0003c; 0.01, and ### <italic>p</italic> &#x0003c; 0.001 vs. HFC.</p></caption><graphic xlink:href="nutrients-12-03859-g003"/></fig><fig id="nutrients-12-03859-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effect of roasted <italic>Nelumbo nucifera</italic> (RN) treatment on the changes in the epididymal fat pad on high fat/high cholesterol (HFC) diet rat. Representative image of the visceral fat distribution of each group (<bold>A</bold>). The red line indicated the degree of visceral fat distribution. Representative microscopic photograph of an epididymal fat pad using the oil red O staining method (<bold>B</bold>). Lower panel indicated the weight (<bold>C</bold>) and size (<bold>D</bold>) of adipose cells. CON, regular diet; HFC, HFC diet; FLU, fluvastatin (3 mg/kg/day) with HFC diet; RNN, RN (100 mg/kg/day) with HFC diet; RNH, RN (200 mg/kg/day) with HFC diet. The values represent the means &#x000b1; standard error. *** <italic>p</italic> &#x0003c; 0.001 vs. CON; # <italic>p</italic> &#x0003c; 0.05 and ## <italic>p</italic> &#x0003c; 0.01 vs. HFC.</p></caption><graphic xlink:href="nutrients-12-03859-g004"/></fig><fig id="nutrients-12-03859-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Effects of roasted <italic>Nelumbo nucifera</italic> (RN) on hepatic histopathology and function in rats fed a high fat/cholesterol (HFC) diet. Histopathological changes were identified within the liver tissue using hematoxylin and eosin staining (<bold>A</bold>). Graph of hepatic triglyceride levels (<bold>B</bold>), AST/ALT ratio in plasma (<bold>C</bold>), and hepatic <italic>LXR</italic> and <italic>SREBP-1</italic> gene expression levels (<bold>D</bold>). CON, regular diet; HFC, HFC diet; FLU, fluvastatin (3 mg/kg/day) with HFC diet; RNN, RN (100 mg/kg/day) with HFC diet; RNH, RN (200 mg/kg/day) with HFC diet; LXR, liver X receptor; SREBP-1c, Sterol regulatory element-binding protein-1c; AST, aspartate aminotransferase; ALT, alanine aminotransferse. The values represent the means &#x000b1; standard error. ** <italic>p</italic> &#x0003c; 0.01 and *** <italic>p</italic> &#x0003c; 0.001 vs. CON; # <italic>p</italic> &#x0003c; 0.05 and ## <italic>p</italic> &#x0003c; 0.01 vs. HFC.</p></caption><graphic xlink:href="nutrients-12-03859-g005"/></fig><fig id="nutrients-12-03859-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Schematic diagram of the effect of roasted <italic>Nelumbo nucifera</italic> (RN) in improving hypertriglyceridemia. TG, triglyceride; FFA, free fatty acid; LXR, liver X receptor; SREBP-1c, Sterol regulatory element-binding protein-1c; VLDL, very-low-density lipoprotein; HDL, high-density lipoprotein; LDL, low-density lipoprotein.</p></caption><graphic xlink:href="nutrients-12-03859-g006"/></fig><table-wrap id="nutrients-12-03859-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-12-03859-t001_Table 1</object-id><label>Table 1</label><caption><p>Effect of roasted <italic>Nelumbo nucifera</italic> (RN) on the change of tissue weight in high fat/cholesterol (HFC) diet rats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Weight (g)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CON</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HFC</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FLU</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RNL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RNH</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Final Body</td><td align="center" valign="middle" rowspan="1" colspan="1">449.41 &#x000b1; 7.67</td><td align="center" valign="middle" rowspan="1" colspan="1">498.13 &#x000b1; 6.88 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">476.53 &#x000b1; 4.43 <sup>#</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">466.39 &#x000b1; 5.44 <sup>#</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">488.60 &#x000b1; 9.26</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Epididymal fat pad</td><td align="center" valign="middle" rowspan="1" colspan="1">2.89 &#x000b1; 0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">4.44 &#x000b1; 0.11 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">3.89 &#x000b1; 0.16 <sup>#</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.41 &#x000b1; 0.17 <sup>###</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.69 &#x000b1; 0.16 <sup>##</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Liver</td><td align="center" valign="middle" rowspan="1" colspan="1">9.37 &#x000b1; 0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">11.01 &#x000b1; 0.36 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">8.81 &#x000b1; 0.49 <sup>##</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.11 &#x000b1; 0.46 <sup>##</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.39 &#x000b1; 0.33 <sup>##</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Heart</td><td align="center" valign="middle" rowspan="1" colspan="1">1.34 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">1.44 &#x000b1; 0.02 *</td><td align="center" valign="middle" rowspan="1" colspan="1">1.41 &#x000b1; 0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">1.39 &#x000b1; 0.04 <sup>#</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.37 &#x000b1; 0.05 <sup>#</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kidney</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.46 &#x000b1; 0.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.59 &#x000b1; 0.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.44 &#x000b1; 0.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.46 &#x000b1; 0.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.36 &#x000b1; 0.03</td></tr></tbody></table><table-wrap-foot><fn><p>CON, regular diet; HFC, HFC diet; FLU, Fluvastatin (3 mg/kg/day) with HFC diet; RNN, RN(100 mg/kg/day) with HFC diet; RNH, RN(200 mg/kg/day) with HFC diet. The values represent the means &#x000b1; standard error. * <italic>p</italic> &#x0003c; 0.05 and *** <italic>p</italic> &#x0003c; 0.001 vs. CON; <sup>#</sup>
<italic>p</italic> &#x0003c; 0.05, <sup>##</sup>
<italic>p</italic> &#x0003c; 0.01, and <sup>###</sup>
<italic>p</italic> &#x0003c; 0.001 vs. HFC.</p></fn></table-wrap-foot></table-wrap></floats-group></article>